Seelos announces FDA acceptance of IND application for SLS-005 for Sanfilippo Syndrome
The FDA has advised Seelos that it may proceed with the proposed clinical trial SLS-005-201 for Mucopolysaccharidosis type III (Sanfilippo syndrome). “We are very pleased to have received